Patients with diabetes are likely to be affected by Diabetic foot ulcers (DFUs). This type of disease is popular and enfeeble, generating a surge of serious morbidity and mortality combined with worldwide socio-economic problems. The symptoms of this disease such as infection and inflammation raise surrounding oedema of the foot. …
Read More »Liraglutide’s Effects in Overweight and Obese Adults at High CV Risk
Liraglutide to positively effect decrease in visceral fat in overweight and obese patients without history of type 2 diabetes. Critical drivers of adverse cardiometabolic outcomes in obese patients are visceral and ectopic fat, which is wrapped around the abdominal organs in the body. This type of fat can lead to …
Read More »Low GI Foods Significantly Reduce Blood Sugar in Diabetes Patients
Low glycemic index foods found to be helpful in lowering A1C and blood sugar in diabetic patients Changes in diet to a low glycemic diet are associated with small but meaningful improvements in lowering blood sugar, weight, cholesterol, and other risk factors found in diabetic patients. These findings are a …
Read More »The impact of a vegan diet in the prevention and treatment of type 2 diabetes: A systematic review
Can a vegan diet that is no meat or dairy products stomp type 2 diabetes… Vegan diets have gained a lot of popularity around the world, mostly in America. About 6% of Americans claim that they are vegans. That is a 600% increase in veganism from 2017 to 2021. There …
Read More »Sickle Cell Disease and Diabetes Mellitus
Is there a link between patients living with sickle cell disease and diabetes mellitus? African-Americans/ Black are the most affected by sickle cell disease (SCD). According to the US Department of Health and Human Services Office of Minority Health, this population also has the highest prevalence of obesity. Sickle cell …
Read More »Influence of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus
Sodium-glucose cotransporter 2 inhibitors lower the risk of hospitalization in heart failure and cardiovascular death… The SIMPLE trial examined the effects of empagliflozin on myocardial flow reserve, showing microvascular perfusion in individuals with type 2 diabetes with high CVD risk. The SIMPLE trial is a single-center, double-blind, randomized clinical trial …
Read More »The Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone: A New Option for Patients with Diabetic Kidney Disease
Allison S. Rembert, PharmD Candidate 2024 Adrian K. Baker, PharmD Candidate 2024 Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 55-year-old female with type 2 diabetes (T2D) and chronic kidney disease (CKD) presented to the ambulatory care clinic. …
Read More »Canagliflozin Effects on NT-proBNP and Heart Failure
Which subgroup of patients with type 2 diabetes and heart failure is more beneficial from treatment with canagliflozin? Patients with type 2 diabetes are at risk for many cardiovascular diseases, including heart failure. In a cohort study published by Nichols et al., patients with type 2 diabetes are more likely …
Read More »Risk of Developing Glaucoma in Postmenopausal Women with Diabetes in Korea
In previous studies, the association between diabetes and glaucoma is controversial. Glaucoma is an irreversible progression of visual field loss that can be asymptomatic at early stages. The mechanisms associating diabetes with glaucoma and the likelihood of diabetes causing glaucoma are unclear. However, diabetes is a known risk factor for …
Read More »Cardiac Dysfunction: Pregnancy in Diabetes as Risk Factor in Babies
Negative long-term effect on cardiac function in babies born from diabetic mothers. Having a disease such as diabetes has many risks and long-term possible cardiovascular effects if not managed well. Furthermore, being a diabetic pregnant patient has even more risks and can lead to complications maternally and congenital complications and …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.